| PROREPAIR-B: a prospective cohort study of the impact of germline DNA repair mutations on the outcomes of patients with metastatic castration-resistant prostate cancer E Castro, N Romero-Laorden, A Del Pozo, R Lozano, A Medina, J Puente, ... Journal of Clinical Oncology 37 (6), 490-503, 2019 | 319 | 2019 |
| The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities SB Paz Nombela, Borja Miguel-López Molecular Cancer, 2021 | 295 | 2021 |
| BRCA2 and other DDR genes in prostate cancer P Nombela, R Lozano, A Aytes, J Mateo, D Olmos, E Castro Cancers 11 (3), 352, 2019 | 92 | 2019 |
| Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells AE Cariaga-Martinez, P López-Ruiz, MP Nombela-Blanco, O Motiño, ... Cellular signalling 25 (7), 1586-1597, 2013 | 60 | 2013 |
| Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus … N Romero-Laorden, R Lozano, A Jayaram, F López-Campos, MI Saez, ... British Journal of Cancer 119 (9), 1052-1059, 2018 | 38 | 2018 |
| Multicentre trial: treatment of Parkinson’s disease with CDP-choline (citicholine) J Acosta, M Nombela, A Palao, M Pastor, J Recuero New Trends in Clinical Neuropharmacology: Calcium antagonists. Acute …, 1988 | 19 | 1988 |
| Value of early circulating tumor cells dynamics to estimate docetaxel benefit in metastatic castration-resistant prostate cancer (mCRPC) patients R Lozano, D Lorente, IM Aragon, N Romero-Laorden, P Nombela, ... Cancers 13 (10), 2334, 2021 | 12 | 2021 |
| METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer R García-Vílchez, AM Añazco-Guenkova, S Dietmann, J López, ... Molecular cancer 22 (1), 119, 2023 | 9 | 2023 |
| Prospective evaluation of the response to prednisone-dexamethasone switch in castration-resistant prostate cancer patients treated with abiraterone pre-and post-docetaxel. N Romero-Laorden, E Castro, R Lozano, MI Sáez, J Valero, F Van de Poll, ... Journal of Clinical Oncology 34 (2_suppl), 327-327, 2016 | 2 | 2016 |
| Value of early circulating tumor cells dynamics to estimate docetaxel benefit in metastatic castration-resistant prostate cancer (mCRPC) patients. Cancers (Basel). 2021; 13 (10) R Lozano, D Lorente, IM Aragon, N Romero-Laorden, P Nombela, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Identification of critical 6-methyladenosine regulators as malignant prognosis factors in prostate adenocarcinoma Ó Monteagudo, P Nombela, S Blanco | | 2021 |
| Identification of RNA modifications relevant for Docetaxel resistance in prostate cancer P Nombela, S Blanco | | 2021 |
| Circulating tumour cells (CTC) count and prostate-specific antigen (PSA) response measures in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated … RL Mejorada, D Lorente, E Castro, D Bianchini, P Nombela, SK Sandhu, ... Annals of Oncology 30, v350, 2019 | | 2019 |
| Docetaxel response characterization and identification of predictive biomarkers in metastatic castration resistant prostate cancer MP Nombela Blanco | | 2019 |
| Docetaxel response characterization and identification of predictive biomarkers in metastatic castration resistant prostate cancer MPN Blanco Universidad Autónoma de Madrid, 2019 | | 2019 |
| Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus … R Lozano, A Jayaram, F López-Campos, MI Saez, A Montesa, ... | | 2018 |
| High-Frequency of TMPRSS2-ERG fusion gene identifies a non-random androgen-driven event of chromosomal instability in BRCA mutated prostate cancer E Castro, F Van de Poll, E Piñeiro, P Nombela, E Bancroft, K Govindasami, ... Cancer Research 75 (15_Supplement), 4249-4249, 2015 | | 2015 |
| MULTICENTRE TRIAL: TREATMENT OF PARKINSON'S DISEASE WITH CDP-CHOLINE (CITICHOLINE) E de la Morena, M Pastor, A Palao, J Recuero, J Acosta, M Nombela, ... New Trends in Clinical Neuropharmacology: Calcium Antagonists, Acute …, 1988 | | 1988 |
